US Patent Issued to JUNTEN BIO on Aug. 26 for "Antibody capable of inducing immune tolerance produced using cell mixture having complexed state, and induced lymphocyte or cell therapeutic agent and cell therapy method each using induced lymphocyte" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,397,054, issued on Aug. 26, was assigned to JUNTEN BIO Co. Ltd. (Tokyo).

"Antibody capable of inducing immune tolerance produced using cell mixture having complexed state, and induced lymphocyte or cell therapeutic agent and cell therapy method each using induced lymphocyte" was invented by Koichiro Uchida (Tokyo), Kazuyoshi Takeda (Tokyo) and Ko Okumura (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a pharmaceutical composition for antigen-specific immune tolerance or immune present suppression. The disclosure provides pharmaceutical composition comprising a CD4-positive anergy T cell and a CD8-positive anergy T c...